C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.

@article{Puri2013CreactivePB,
  title={C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.},
  author={Rishi Puri and Steven Evan Nissen and P. Scott Libby and Mingyuan Shao and Christie M. Ballantyne and Phillip J. Barter and M John Chapman and R. Erbel and Joel S. Raichlen and Kiyoko Uno and Yu Kataoka and Stephen J Nicholls},
  journal={Circulation},
  year={2013},
  volume={128 22},
  pages={2395-403}
}
BACKGROUND Baseline C-reactive protein (CRP) levels predict major adverse cardiovascular events (MACE: death, myocardial infarction, stroke, coronary revascularization, and hospitalization for unstable angina). The association between changes in CRP levels with plaque progression and MACE in the setting of maximally intensive statin therapy is unknown. METHODS AND RESULTS The Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin (SATURN) used… CONTINUE READING